13-Jun-2022 | Facts and Factors
According to Facts and Factors, the global drug delivery in cancer market was valued at USD 1527.40 million in 2021 and is predicted to increase at a CAGR of 6.70% to USD 2253.92 million by 2028. The study examines the market in terms of revenue in each of the major regions, which are classified into countries.
The uncontrolled proliferation of aberrant cells is classified as cancer. In today's disease treatment systems, radiation, chemotherapy, and medical procedures are all used. Because traditional drug delivery tactics for malignant cell growth chemotherapy might destroy healthy cells, it's only utilized for the most serious tumors. A targeted drug delivery system (TDDS) is a framework for delivering medication to a predetermined place in a controlled manner. Polymers are important in the construction of nanoparticulate transporters for disease treatment, and nanotechnology-based conveyance frameworks have a substantial impact on cancer treatment.
Browse the full “Drug Delivery in Cancer Market By Product (Liposome, PE Gylated Proteins & Polypeptides, Polymer Nanoparticle, Protein–drug Conjugates), By Application (Hospitals & Clinic, Cancer Treatment Centers, Others), and By Region - Global Industry Overview, Market Size, Share, Statistical Research, Market Intelligence, Comprehensive Analysis, Trends, and Forecast 2022–2028" report at https://www.fnfresearch.com/drug-delivery-in-cancer-market
Nanotherapeutic drug delivery systems provide significant benefits such as delayed half-life, improved bio-dissemination, extended medication course season, controlled and supported medication arrival, the flexibility of course of organization, and expanded intercellular grouping of medication, to name a few (NDDS). Nanotechnology-based targeted medication systems can successfully deliver precise amounts of therapeutic drugs to patients. However, a lack of awareness about modern medicine systems in impoverished regions, as well as a paucity of trained medical practitioners, is predicted to stymie market progress in the region. Furthermore, the high costs of cancer research and clinical trials may inhibit market development in economically disadvantaged countries such as Sudan and Somalia.
The global market for cancer drug delivery is segmented by product, application, and geography. In terms of product, the Polymer Nanoparticle was the most popular in the global drug delivery in cancer market in 2020. As unique drug delivery technologies, nanoparticles constitute a novel cancer treatment technique. By encapsulating the drugs, they preserve them from chemical and enzymatic destruction. Nanoparticles in pharmaceutical administration have long circulation half-lives, fewer side effects, and superior pharmacokinetics. These particles also have higher permeability, making medicine delivery to cancer tissues more efficient.
Cancer centers will have the greatest percentage of applications. Increased awareness of optional treatment alternatives, combined with an increase in cancer diagnoses around the world, is predicted to promote market expansion for drug delivery systems. In addition, the usage of nanoparticles to treat diseases in a range of countries is likely to drive market expansion. The growing number of major market participants who are increasing their interest in drug delivery system research and development, as well as a growing product portfolio and administrative endorsements, are projected to propel market growth even faster.
North America is expected to lead the market due to increased cancer incidences in the region, as well as a growing senior population and the resulting need for sophisticated therapy procedures. An increase in clinical trials for new treatment mechanisms, an increase in drug discovery spending plans, an increase in the number of regional players, an increase in the occurrence of malignancy, and FDA approvals for NDDS business accessibility are among the other key factors driving the growth of this market. Because of rising cancer rates in China and Japan, Japan's growing senior population, and joint product development activities between the US and Japan, the Asia Pacific market for drug delivery systems in cancer therapy is expected to rise significantly in the coming years.
Report Scope
Report Attribute |
Details |
Market Size in 2021 |
USD 1527.40 million |
Projected Market Size in 2028 |
USD 2253.92 million |
CAGR Growth Rate |
6.70% CAGR |
Base Year |
2021 |
Forecast Years |
2022-2028 |
Key Market Players |
Amgen, Teva, UCB (Union Chimique Belge), Roche, Celgene, Sanofi, Merck, Johnson & Johnson, Takeda, Gilead Sciences All Market Inc., and Others |
Key Segment |
By Product, Application, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Some of the major companies operating in the drug delivery in cancer market are; Amgen, Teva, UCB (Union Chimique Belge), Roche, Celgene, Sanofi, Merck, Johnson & Johnson, Takeda, and others.
The Global Drug Delivery in Cancer Market is segmented as follows:
By Product
- Liposome
- PE Gylated Proteins & Polypeptides
- Polymer Nanoparticle
- Protein–drug Conjugates
By Application
- Hospitals & Clinic
- Cancer Treatment Centers
- Others
By Region
- North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com
